Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0019209 (
hepatomegaly
)
5,798
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Schistosomiasis japonica remains endemic in several provinces south of the Yangtze River in China because of relatively sparse populations of human beings and dense populations of snails. We studied two brigades in a rural commune in Gui-chi County, Anhui Province, to determine the prevalence, intensity, and morbidity associated with this infection before concerted control efforts were instituted. Quantitative fecal examinations, histories, and physical examinations relevant to
schistosomiasis
japonica were performed in 96 per cent of the available population 2 to 65 years of age. The prevalence was 26.3 per cent in Brigade A (778 persons) and 14.4 per cent in Brigade B (1532 persons). Clinical symptoms and signs were compared among uninfected persons and persons at three levels of infection as determined by fecal egg output. Some increased weakness was seen only at the heaviest levels of infection; abdominal pain was not an important symptom.
Hepatomegaly
was somewhat more frequent in moderate and heavy infections, but splenomegaly was rare and unrelated to intensity of infection. Neither stool consistency nor occult blood was related to the presence or intensity of infection. Approximately 50 per cent of the population had been treated for
schistosomiasis
japonica, 25 per cent repeatedly.
...
PMID:Morbidity in schistosomiasis japonica in relation to intensity of infection. A study of two rural brigades in Anhui Province, China. 665 48
Golden hamsters were used to determine whether intraperitoneal Zn supplementation can improve the outcome of infection with Schistosoma mansoni. The animals were divided into two groups; one received an initial intraperitoneal dose of Zn chloride (0.75 mg 100 g body wt.-1) followed by booster doses (0.25 mg 100 g body wt.-1) twice weekly for four weeks, the other group received no Zn supplement. After one week, when the initial and one booster doses were given, half of the animals in each group were exposed to S. mansoni cercariae for two hours using body immersion technique. After five weeks (one week after the final Zn supplement) the animals were killed, their worm burdens determined and their livers, kidneys, spleens, hearts and sera examined. There was a significant reduction in total worm counts in the Zn supplemented group (P less than 0.05). Also, Zn supplementation of infected animals protected them against the
hepatomegaly
which is very often associated with
schistosomiasis
. Spleen weight and Zn uptake were highest in the infected Zn supplemented group, indicating that this organ requires larger amounts of Zn to perform its various Zn-dependent immunological functions. The data suggest that Zn may enhance the ability of the body organs to resist some of the harmful effects of schistosomal infection.
...
PMID:Effect of zinc supplementation on S. mansoni-infected hamsters. 666 Sep 57
We review asymptomatic splenomegaly in Indochinese refugees and provide recommendations for evaluation of the problem. Prevalence of splenomegaly in newly arrived Indochinese refugees was 2.5%, three times more prevalent in the Hmong than in the non-Hmong refugees. Male Hmong refugees aged 15 to 29 years had the highest prevalence (10%). For the 50 Hmong refugees studied, there was no evidence that their splenomegaly was caused by clonorchiasis,
schistosomiasis
, tuberculosis, syphillis, lymphoma, tropical splenomegaly syndrome, or clinical malaria. Cases were more likely to have
hepatomegaly
, hepatitis B surface antigen positivity, and a low mean corpuscular volume than a reference population of Hmong refugees. Malaria antibody titers were elevated in all but one of the 41 cases (98%) tested.
...
PMID:Splenomegaly in Hmong refugees. 669 60
From this comparison of 37 black children with hepatic
schistosomiasis
(HS) and 53 with intestinal Schistosoma mansoni (IS) living in an endemic area, we propose easily identifiable clinical features of mild HS. These patients were generally well nourished school-age children who seldom complained of dysentery but who had a firm
hepatomegaly
with predominant enlargement of the left lobe and a firm splenomegaly. They were also mildly anaemic (9.4 +/- 2.2 g/dl) and had low serum albumin (30 +/- 7 g/l), raised aspartate transaminase (36 +/- 31 u/l) and high globulins (53 +/- 15 g/l). The implications of the absence of severe hepatosplenic
schistosomiasis
in many of these children are discussed.
...
PMID:Clinical recognition of mild hepatic schistosomiasis in an endemic area. 671 May 66
Praziquantel is a newly developed drug effective in the treatment of
schistosomiasis
. In order to assess the efficacy and toxicity of praziquantel in the treatment of Schistosoma mekongi, 11 infected Laotian refugees, all belonging to a single extended family, were treated in a double-blind crossover trial with praziquantel and placebo. Initially, one group of five received praziquantel 60 mg/kg body weight in three divided doses orally while the remainder received an identically appearing placebo. Patients were evaluated clinically before, during and following therapy for 2 days. After 2.5 months the patients were re-evaluated and subjected to the opposite treatment, and final follow-up took place 5-7 months later. Three other patients were treated using an open protocol. All but one person was cured (91%). This patient failed to show a decrease in egg excretion 2.5 weeks after praziquantel therapy and was lost to follow-up thereafter. Side effects were common and consisted primarily of abdominal pain, malaise, and fever. These were generally mild and transient. No abnormal laboratory findings were associated with praziquantel therapy. At the final evaluation 6/6 patients with initial
hepatomegaly
showed a decrease in liver size.
...
PMID:Treatment of Schistosoma mekongi with praziquantel: a double-blind study. 675 Nov 16
In Eseka and Edea
bilharziasis
caused by S. intercalatum is transmitted by B. forskali, the only intermediate host of human schistosomes found in the area. The prevalence of the disease is obtained by calculating the percentage of inhabitants voiding eggs in their stools in the districts of the towns located in the neighbourhood of Bulinus-containing streams and ponds. The prevalence is low, 5,6% in Eseka and 4,9% in Edea. The size and the number of waterbodies where transmission occurs is small. Rectoscopy showed that rectal and sigmoid lesions are frequently seen. Clinical manifestations are abdominal pain, diarrhoea, dysentery, tenesmus, appearance of blood in the stools.
Hepatomegaly
and splenomegaly occur sometimes. A single dose of 2-cyclohexylcarbonyl-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a] isoquinolin-4-one (praziquantel, EMBAY 8440, Biltricide) is effective in the treatment of the disease.
...
PMID:[Epidemiological study of foci of S. intercalatum schistosomiasis in Eseka and Edea (Cameroon). Effects of treatment with praziquantel]. 719 50
Schistosoma mekongi is a newly recognized species of Schistosoma that is closely related to Schistosoma japonicum and is pathogenic to humans. Like the other forms of
schistosomiasis
in which the parasites reside in the mesenteric vasculature, S. mekongi infection has hepatosplenomegaly and portal venous hypertension as its most common serious sequelae.
Schistosomiasis
, although endemic in certain areas of Southeast Asia, has not been recognized as a health problem in Asian refugees who are currently entering the United States. In the present study 12 Laotian immigrants with S. mekongi infection were examined. The clinical, laboratory, and parasitologic findings in these patients are discussed. The diagnosis was made by examination of stool specimens in 11 patients and rectal biopsy specimens in one patient. All patients were asymptomatic, although the six youngest children had
hepatomegaly
. It is suggested that specific serologic tests may be useful in screening Asian refugees for infection with Schistosoma.
...
PMID:Infection with Schistosoma mekongi in Southeast Asian refugees. 731 Jan 75
This study was carried out to demonstrate hepatitis "E" virus antibodies (IgG) among individuals living in different rural areas. The study included 200 individuals. One hundred were suffering from S. mansoni as confirmed by stool egg count, rectal snip, abdominal ultrasound and liver biopsy. The second hundred (Group II) were parasite-free individuals serving as normal control. The main symptoms of group I were dyspepsia, fatigue, dysentery, bleeding per rectum and
hepatomegaly
. There was no significant difference in the transaminase levels (SGPT and SGOT) between both groups. The prevalence of HEV-ab (ab (IgM) among group I was 31% and group II, 14% with a highly significant increase in group I. There was no correlation between the number of egg count in stools and HEV infectivity. Thus, the prevalence of HEV was higher in the rural areas and in
schistosomiasis
patients in particular, due to low sociohygienic conditions under which the patients are living. Also
schistosomiasis
may play a role in virus infection by altering the immune system.
...
PMID:Risk of hepatitis "E" virus infection among some schistosomiasis patients in Egypt. 760 54
Clinical gastro-intestinal manifestations were studied in 34 patients in the initial phase of
schistosomiasis
mansoni. The patients, all men, were of similar age and in similar nutritional condition and had been infected simultaneously at the same transmission site. Most (85%) showed some gastro-intestinal sign or symptom, generally of light or moderate intensity; 56% had liquid or pasty diarrhoea, 41% abdominal pain, 29%
hepatomegaly
, 21% dysentery, 15% anorexia, 12% pain on colon palpation and 9% nausea and/or vomiting. High worm burden was associated with blood in faeces but apparently not with any other clinical manifestation. There was no apparent association between any clinical manifestation and peripheral-blood eosinophil counts or titres of IgE specific for Schistosoma mansoni (evaluated by the area of immediate intradermal reaction to injected adult worm antigen). The absence of association between worm burden and nearly all the clinical gastro-intestinal manifestations strengthens the concept that factors other than worm burden, such as host reactivity, constitute important pathogenetic elements in the initial phase of
schistosomiasis
mansoni.
...
PMID:Gastro-intestinal manifestations of the initial phase of schistosomiasis mansoni. 766 18
Hepatic fibrosis due to
schistosomiasis
japonica was examined by ultrasonography in a cross-sectional community study of 825 individuals on Jishan Island, Jiangxi Province, China. The prevalence of active infection was 39.4% with peak infection in the 10-19.9 years age group followed by a significant decline. A similar pattern was observed for intensity of infection. The prevalence of
hepatomegaly
in the midsternal line > or = 6 cm peaked at 60% in the fourth decade and remained elevated. A progressive increase in the severity of hepatic periportal fibrosis was observed with age, with advanced fibrosis peaking in the fifth decade. The proportion of individuals with advanced fibrosis was significantly greater in males than in females despite equivalent prevalence and intensity of schistosome infection. In addition, a positive association (P < 0.01) was found between periportal fibrosis and both
hepatomegaly
> or = 6 cm and splenomegaly. This study suggests that the natural history of
schistosomiasis
japonica in this hyperendemic community in China is marked by persistence of
hepatomegaly
and schistosome-induced periportal fibrosis in adults despite a decrease in the prevalence of infection.
...
PMID:Schistosomiasis japonica on Jishan Island, Jiangxi Province, People's Republic of China: persistence of hepatic fibrosis after reduction of the prevalence of infection with age. 823 95
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>